Rybelsus
Rybelsus is a diabetes medication containing Semaglutide, available as 3/7/14mg tablets.
- Category
- Diabetes · Weight Loss
- Active ingredient
- Semaglutide
- Route
- Oral use
- Form
- Tablet
- Strengths
- 3/7/14mg
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Rybelsus vary by country.
Details
- Conditions
- Type 2 diabetes mellitus
- Alternative Name
- Ozempic, Wegovy
- Therapeutic Class
- Glucagon-like Peptide-1 (GLP-1) Receptor Agonist
- Pharmacological Class
- GLP-1 Receptor Agonist
- Known Off-label Uses
- obesity
- Minor Side Effects
- nausea, diarrhoea
- Moderate Side Effects
- vomiting, abdominal pain, constipation
- Dosage Forms
- Tablet
- Administration Route
- Oral use
- Prescription Status
- Prescription medicine
- Originator
- Novo Nordisk
- Onset Time
- weeks
- Duration
- long term
- Storage Instructions
- Store in original card in a dry place.
- Drug Interactions
- insulin, sulphonylureas
- Age Restrictions
- 18 years and older.
What you will receive
Rybelsus is the originator brand name, made by Novo Nordisk. We use it here to identify the medicine only; we are not affiliated with Novo Nordisk and do not ship the original Rybelsus.
- You receive a generic equivalent: the same active ingredient (Semaglutide) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.